Sleep and breast cancer: Is there a link?;Sommeil et cancer du sein: existe-t-il un lien?

Gynecologie Obstetrique et Fertilite

Volumn 41, Issue 2, 2013, Pages 105-109

  Malina, C ^a   Frigo, S ^a   Mathelin, C ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

6MT; Breast cancer; Melatonin; Sleep duration

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ARTICLE; BREAST CANCER; CANCER RISK; HORMONE SYNTHESIS; HUMAN; SLEEP; SYSTEMATIC REVIEW;

EID: 84873996487     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2012.12.008     Document Type: Article

References (30)

1. M.P. Madigan, R.G. Ziegler, J. Benichou, C. Byrne, and R.N. Hoover Proportion of breast cancer cases in the United States explained by well-established risk factors J Natl Cancer Inst 87 22 1995 1681 1685
2. A.N. Viswanathan, and E.S. Schernhammer Circulating melatonin and the risk of breast and endometrial cancer in women Cancer Lett 281 1 2009 1 7
3. C. Abrial, F. Kwiatkowski, R. Chevrier, F. Gachon, H. Cure, and P. Chollet Therapeutic potential of melatonin in cancer treatment Pathol Biol (Paris) 53 5 2005 265 268 (Pubitemid 40797973)
4. A.B. Lerner, J.D. Case, and Y. Takahashi Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands J Biol Chem 235 1960 1992 1997
5. E.J. Sanchez-Barcelo, S. Cos, R. Fernandez, and M.D. Mediavilla Melatonin and mammary cancer: a short review Endocr Relat Cancer 10 2 2003 153 159 (Pubitemid 36758644)
6. E.J. Sanchez-Barcelo, S. Cos, D. Mediavilla, C. Martinez-Campa, A. Gonzalez, and C. Alonso-Gonzalez Melatonin-estrogen interactions in breast cancer J Pineal Res 38 4 2005 217 222 (Pubitemid 41475432)
7. A. Gonzalez, V. Alvarez-Garcia, C. Martinez-Campa, C. Alonso-Gonzalez, and S. Cos Melatonin promotes differentiation of 3T3-L1 fibroblasts J Pineal Res 52 1 2012 12 20
8. K.C. Knower, S.Q. To, K. Takagi, Y. Miki, H. Sasano, and E.R. Simpson Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts Breast Cancer Res Treat 132 2 2012 765 771
9. P.T. Ram, J. Dai, L. Yuan, C. Dong, T.L. Kiefer, and L. Lai Involvement of the mt1 melatonin receptor in human breast cancer Cancer Lett 179 2 2002 141 150 (Pubitemid 34215105)
10. R. Girgert, V. Hanf, G. Emons, and C. Grundker Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells J Pineal Res 47 1 2009 23 31
11. D.E. Blask, S.M. Hill, R.T. Dauchy, S. Xiang, L. Yuan, and T. Duplessis Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night J Pineal Res 51 3 2011 259 269
12. P.K. Verkasalo, K. Lillberg, R.G. Stevens, C. Hublin, M. Partinen, and M. Koskenvuo Sleep duration and breast cancer: a prospective cohort study Cancer Res 65 20 2005 9595 9600 (Pubitemid 41508031)
13. S.P. Pinheiro, E.S. Schernhammer, S.S. Tworoger, and K.B. Michels A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women Cancer Res 66 10 2006 5521 5525 (Pubitemid 43844981)
14. A.H. Wu, R. Wang, W.P. Koh, F.Z. Stanczyk, H.P. Lee, and M.C. Yu Sleep duration, melatonin and breast cancer among Chinese women in Singapore Carcinogenesis 29 6 2008 1244 1248 (Pubitemid 351958705)
15. M. Kakizaki, S. Kuriyama, T. Sone, K. Ohmori-Matsuda, A. Hozawa, and N. Nakaya Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study Br J Cancer 99 9 2008 1502 1505
16. J.A. McElroy, P.A. Newcomb, L. Titus-Ernstoff, A. Trentham-Dietz, J.M. Hampton, and K.M. Egan Duration of sleep and breast cancer risk in a large population-based case-control study J Sleep Res 15 3 2006 241 249 (Pubitemid 44215540)
17. E.S. Schernhammer, and S.E. Hankinson Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort Cancer Epidemiol Biomarkers Prev 18 1 2009 74 79
18. E.S. Schernhammer, F. Berrino, V. Krogh, G. Secreto, A. Micheli, and E. Venturelli Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 100 12 2008 898 905 (Pubitemid 351881952)
19. E.S. Schernhammer, F. Berrino, V. Krogh, G. Secreto, A. Micheli, and E. Venturelli Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort Cancer Epidemiol Biomarkers Prev 19 3 2010 729 737
20. R.C. Travis, D.S. Allen, I.S. Fentiman, and T.J. Key Melatonin and breast cancer: a prospective study J Natl Cancer Inst 96 6 2004 475 482 (Pubitemid 38443651)
21. E.S. Schernhammer, and S.E. Hankinson Urinary melatonin levels and breast cancer risk J Natl Cancer Inst 97 14 2005 1084 1087 (Pubitemid 41417926)
22. D.S. Lauderdale, K.L. Knutson, L.L. Yan, K. Liu, and P.J. Rathouz Self-reported and measured sleep duration: how similar are they? Epidemiology 19 6 2008 838 845
23. C.M. Alfano, K.L. Lichstein, G.S. Vander Wal, A.W. Smith, B.B. Reeve, and A. McTiernan Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life Breast Cancer Res Treat 130 1 2011 243 254
24. R.G. Stevens Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world Mutat Res 680 1-2 2009 106 108
25. R.G. Stevens Light-at-night, circadian disruption and breast cancer: assessment of existing evidence Int J Epidemiol 38 4 2009 963 970
26. R.A. Hahn Profound bilateral blindness and the incidence of breast cancer Epidemiology 2 3 1991 208 210
27. J. Kliukiene, T. Tynes, and A. Andersen Risk of breast cancer among Norwegian women with visual impairment Br J Cancer 84 3 2001 397 399 (Pubitemid 32154435)
28. E.S. Schernhammer, A. Giobbie-Hurder, K. Gantman, J. Savoie, R. Scheib, and L.M. Parker A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers Cancer Causes Control 23 4 2012 609 616
29. D.E. Blask Melatonin, sleep disturbance and cancer risk Sleep Med Rev 13 4 2009 257 264
30. F. Menegaux, T. Truong, A. Anger, E. Cordina-Duverger, F. Lamkarkach, and P. Arveux Night work and breast cancer: a population-based case-control study in France (the CECILE study) Int J Cancer 132 4 2012 924 931